{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T09:40:34Z","timestamp":1733046034009,"version":"3.30.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,1]]},"DOI":"10.7759\/cureus.74891","type":"journal-article","created":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T09:25:14Z","timestamp":1733045114000},"source":"Crossref","is-referenced-by-count":0,"title":["Frequency of Gallbladder Carcinoma in Patients Operated for Symptomatic Cholelithiasis"],"prefix":"10.7759","author":[{"given":"Muhammad","family":"Alam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asma","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikmat Ullah","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Bilawal","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farah","family":"Deeba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Gohar","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.21037\/jgo-22-61","article-title":"Clinicopathological prognostic factors for gallbladder carcinoma: a retrospective study","volume":"13","author":"Ramalhosa F","year":"2022","unstructured":"Ramalhosa F, Amaral MJ, Ser\u00f4dio M, Oliveira RC, Teixeira P, Cipriano MA, Tralh\u00e3o JG. Clinicopathological prognostic factors for gallbladder carcinoma: a retrospective study. J Gastrointest Oncol. 2022, 13:1997-2006. 10.21037\/jgo-22-61","journal-title":"J Gastrointest Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-018-0099-y","article-title":"Prognostic factors for operated gallbladder cancer","volume":"50","author":"Oven Ustaalioglu BB","year":"2019","unstructured":"Oven Ustaalioglu BB, Bilici A, Seker M, et al.. Prognostic factors for operated gallbladder cancer. J Gastrointest Cancer. 2019, 50:451-457. 10.1007\/s12029-018-0099-y","journal-title":"J Gastrointest Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-249. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2022.106234","article-title":"Current management of incidental gallbladder cancer: a review","volume":"98","author":"Feo CF","year":"2022","unstructured":"Feo CF, Ginesu GC, Fancellu A, et al.. Current management of incidental gallbladder cancer: a review. Int J Surg. 2022, 98:106234. 10.1016\/j.ijsu.2022.106234","journal-title":"Int J Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00153-7","article-title":"Biliary tract cancer","volume":"397","author":"Valle JW","year":"2021","unstructured":"Valle JW, Kelley RK, Nervi B, et al.. Biliary tract cancer. Lancet. 2021, 397:428-444. 10.1016\/S0140-6736(21)00153-7","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000000728","article-title":"Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study","volume":"261","author":"Shindoh J","year":"2015","unstructured":"Shindoh J, de Aretxabala X, Aloia TA, et al.. Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study. Ann Surg. 2015, 261:733-739. 10.1097\/SLA.0000000000000728","journal-title":"Ann Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v12.i9.641","article-title":"Surgical treatment of gallbladder cancer: an eight-year experience in a single center","volume":"12","author":"Kamada Y","year":"2020","unstructured":"Kamada Y, Hori T, Yamamoto H, et al.. Surgical treatment of gallbladder cancer: an eight-year experience in a single center. World J Hepatol. 2020, 12:641-660. 10.4254\/wjh.v12.i9.641","journal-title":"World J Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.suc.2018.12.008","article-title":"Gallbladder cancer: diagnosis, surgical management, and adjuvant therapies","volume":"99","author":"Hickman L","year":"2019","unstructured":"Hickman L, Contreras C. Gallbladder cancer: diagnosis, surgical management, and adjuvant therapies. Surg Clin North Am. 2019, 99:337-355. 10.1016\/j.suc.2018.12.008","journal-title":"Surg Clin North Am"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i22.3978","article-title":"Gallbladder cancer epidemiology, pathogenesis and molecular genetics: recent update","volume":"23","author":"Sharma A","year":"2017","unstructured":"Sharma A, Sharma KL, Gupta A, Yadav A, Kumar A. Gallbladder cancer epidemiology, pathogenesis and molecular genetics: recent update. World J Gastroenterol. 2017, 23:3978-3998. 10.3748\/wjg.v23.i22.3978","journal-title":"World J Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1429","article-title":"Gallbladder cancer: lessons from a rare tumour","volume":"4","author":"Wistuba II","year":"2004","unstructured":"Wistuba II, Gazdar AF. Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer. 2004, 4:695-706. 10.1038\/nrc1429","journal-title":"Nat Rev Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3892\/or.8.5.1127","article-title":"Expression of the c-erb-B2 and p53 protein in gallbladder carcinomas","volume":"8","author":"Kim YW","year":"2001","unstructured":"Kim YW, Huh SH, Park YK, Yoon TY, Lee SM, Hong SH. Expression of the c-erb-B2 and p53 protein in gallbladder carcinomas. Oncol Rep. 2001, 8:1127-1132. 10.3892\/or.8.5.1127","journal-title":"Oncol Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S175681","article-title":"CD44 is overexpressed and correlated with tumor progression in gallbladder cancer","volume":"10","author":"He Y","year":"2018","unstructured":"He Y, Xue C, Yu Y, et al.. CD44 is overexpressed and correlated with tumor progression in gallbladder cancer. Cancer Manag Res. 2018, 10:3857-3865. 10.2147\/CMAR.S175681","journal-title":"Cancer Manag Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2011.198","article-title":"HER2 testing in gastric cancer: a practical approach","volume":"25","author":"R\u00fcschoff J","year":"2012","unstructured":"R\u00fcschoff J, Hanna W, Bilous M, et al.. HER2 testing in gastric cancer: a practical approach. Mod Pathol. 2012, 25:637-650. 10.1038\/modpathol.2011.198","journal-title":"Mod Pathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s004230000177","article-title":"How to proceed in patients with carcinoma detected after laparoscopic cholecystectomy","volume":"385","author":"Frauenschuh D","year":"2000","unstructured":"Frauenschuh D, Greim R, Kraas E. How to proceed in patients with carcinoma detected after laparoscopic cholecystectomy. Langenbecks Arch Surg. 2000, 385:495-500. 10.1007\/s004230000177","journal-title":"Langenbecks Arch Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5009\/gnl.2012.6.2.172","article-title":"Epidemiology of gallbladder disease: cholelithiasis and cancer","volume":"6","author":"Stinton LM","year":"2012","unstructured":"Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver. 2012, 6:172-187. 10.5009\/gnl.2012.6.2.172","journal-title":"Gut Liver"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1159\/000503100","article-title":"A preoperative scoring system to predict carcinoma in patients with gallbladder polyps","volume":"37","author":"Onda S","year":"2020","unstructured":"Onda S, Futagawa Y, Gocho T, Shiba H, Ishida Y, Okamoto T, Yanaga K. A preoperative scoring system to predict carcinoma in patients with gallbladder polyps. Dig Surg. 2020, 37:275-281. 10.1159\/000503100","journal-title":"Dig Surg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21683","article-title":"Gallbladder cancer worldwide: geographical distribution and risk factors","volume":"118","author":"Randi G","year":"2006","unstructured":"Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006, 118:1591-1602. 10.1002\/ijc.21683","journal-title":"Int J Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/ans.16452","article-title":"Characteristics and survival prognosis of patients with pure squamous cell carcinoma of the gallbladder","volume":"91","author":"Zhu C","year":"2021","unstructured":"Zhu C, Sun L, Wei Y, Xu D, Zhou Y. Characteristics and survival prognosis of patients with pure squamous cell carcinoma of the gallbladder. ANZ J Surg. 2021, 91:E91-E97. 10.1111\/ans.16452","journal-title":"ANZ J Surg"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-018-5103-7","article-title":"Establishment of a gallbladder cancer-specific survival model to predict prognosis in non-metastatic gallbladder cancer patients after surgical resection","volume":"63","author":"Zhang W","year":"2018","unstructured":"Zhang W, Hong HJ, Chen YL. Establishment of a gallbladder cancer-specific survival model to predict prognosis in non-metastatic gallbladder cancer patients after surgical resection. Dig Dis Sci. 2018, 63:2251-2258. 10.1007\/s10620-018-5103-7","journal-title":"Dig Dis Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2018.05.007","article-title":"A predictive model for survival of gallbladder adenocarcinoma","volume":"27","author":"Yifan T","year":"2018","unstructured":"Yifan T, Zheyong L, Miaoqin C, Liang S, Xiujun C. A predictive model for survival of gallbladder adenocarcinoma. Surg Oncol. 2018, 27:365-372. 10.1016\/j.suronc.2018.05.007","journal-title":"Surg Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le DT","year":"2017","unstructured":"Le DT, Durham JN, Smith KN, et al.. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science. 2017, 357:409-413. 10.1126\/science.aan6733","journal-title":"Science"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/00008469-200308000-00005","article-title":"Lifestyle, parity, menstrual and reproductive factors and risk of gallbladder cancer","volume":"12","author":"Pandey M","year":"2003","unstructured":"Pandey M, Shukla VK. Lifestyle, parity, menstrual and reproductive factors and risk of gallbladder cancer. Eur J Cancer Prev. 2003, 12:269-272. 10.1097\/00008469-200308000-00005","journal-title":"Eur J Cancer Prev"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-019-0813-5","article-title":"Low frequency of mismatch repair deficiency in gallbladder cancer","volume":"14","author":"Goeppert B","year":"2019","unstructured":"Goeppert B, Roessler S, Renner M, et al.. Low frequency of mismatch repair deficiency in gallbladder cancer. Diagn Pathol. 2019, 14:36. 10.1186\/s13000-019-0813-5","journal-title":"Diagn Pathol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2014.02.008","article-title":"HER2 aberrations in cancer: implications for therapy","volume":"40","author":"Yan M","year":"2014","unstructured":"Yan M, Parker BA, Schwab R, Kurzrock R. HER2 aberrations in cancer: implications for therapy. Cancer Treat Rev. 2014, 40:770-780. 10.1016\/j.ctrv.2014.02.008","journal-title":"Cancer Treat Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/318848-frequency-of-gallbladder-carcinoma-in-patients-operated-for-symptomatic-cholelithiasis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T09:25:15Z","timestamp":1733045115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/318848-frequency-of-gallbladder-carcinoma-in-patients-operated-for-symptomatic-cholelithiasis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,1]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.74891","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,1]]}}}